Company News 28 Oct 2021 Orthocell featured as a Case Study in the Australian Regenerative Medicine Therapies Report Orthocell’s CelGro™ technology has been featured as one of only four case studies in the recent Australian Regenerative Medicine Therapies… Orthocell
Company News 28 Oct 2021 Investor Presentation | Canaccord Genuity South-West Connect ASX Showcase Orthocell MD, Paul Anderson, presented at the Canaccord Genuity South-West Connect ASX Showcase today to share the latest news and… Orthocell
